Rubedo Life Sciences

Rubedo Life Sciences is a biopharmaceutical company dedicated to developing a broad portfolio of innovative therapeutic products that target cells driving chronic aging-related diseases. Our proprietary ALEMBIC™ drug discovery platform designs novel, first-in-class small molecules aimed at selectively targeting senescent cells, which play a critical role in the progression of pulmonary diseases, cancer, neurodegenerative disorders, fibrosis, and other chronic conditions. The Rubedo leadership team consists of industry leaders and early pioneers in chemistry, technology, and life sciences, with expertise in drug development and commercialization from large pharmaceutical companies and leading biotechnology firms.